Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 210

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9C
Chunk 210
---
”), which
consists of three independent directors: Julie Kampf, Holger Weis and Nicholas H. Hemmerly. Ms. Kampf is the chair of the Nominating
and Corporate Governance Committee. Our Nominating and Corporate Governance Committee operates under a written charter, a copy of which
is posted on the Corporate Governance section of our website, at www.jupiterneurosciences.com.

The
functions of the Nominating and Corporate Governance Committee, among other things, include:

    ●
    identifying
    individuals qualified to become board members and recommending director;

    ●
    nominees
    and board members for committee membership;

    ●
    developing
    and recommending to our board corporate governance guidelines;

    ●
    review
    and determine the compensation arrangements for directors; and

    ●
    overseeing
    the evaluation of our board of directors and its committees and management.

101

Director
Nominations

Our
full Board of Directors recommends candidates for nomination for election at the annual meeting of the stockholders. We have not formally
established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general,
in identifying and evaluating nominees for director, the Board of Directors considers educational background, diversity of professional
experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best
interests of our stockholders. 

Board
and Committee Meetings and Director Attendance

During
the year ended December 31, 2024, the Board held five meetings, the Audit Committee held four meetings, the Compensation Committee
held no meetings, and the Nominating and Governance Committee held no meetings.  During 2024, each director attended
more than 75% of the combined meetings of the Board and each committee on which he or she served. 

Compensation
Committee Interlocks and Insider Participation

None
of our executive officers currently serves, or in the past year has served, as a member of the Board of Directors or compensation committee
of any entity that has one or more executive officers on our Board of Directors or Compensation Committee. For a description of transactions
between us and members of our Compensation Committee and affiliates of such members, please see “Certain Relationships and Related
Party Transactions”.

Code
of Ethics

The
Company has adopted a Code of Ethics and Business Conduct that applies to all of its directors, officers (including our principal executive
officer, principal